Navigation Links
ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
Date:3/27/2013

FORT WASHINGTON, Pa. and TOKYO, March 27, 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research organization (CRO), and Asklep Inc. ("Asklep"), one of Japan's largest CROs, today announced the creation of a Joint Venture Company (JVC) to deliver leading-edge R&D outsourcing solutions in Japan to the biopharmaceutical and medical device industries. 

The exclusive RPS-Asklep collaboration will leverage RPS' proprietary structures and global footprint to deliver customized solutions across large, mid-size and small and virtual organizations. A breadth of options ranging from embedded, hybrid, and full-service solutions will be available to clients using best-in-class standard operating procedures, processes and systems.  Alan Morgan , RPS' Chief Operating Officer, will assume the role of Chief Executive Officer (CEO) of the JVC, in addition to his current responsibilities.

Commenting upon the announcement Daniel Perlman , CEO and Founder of RPS said, "By combining RPS' innovative approaches to meeting the industry's needs with Asklep's excellent reputation, significant size, and local infrastructure, RPS will be positioned to meet current and future needs across the biopharmaceutical and medical device industries.  Japan is an important market for clinical development and this JVC brings ownership and accountability with mutual success and long-term stability to the benefit of customers."

Hiroshi Ichikawa , President and CEO of Asklep said, "We are delighted to partner with RPS as it provides very unique solutions ranging from embedded, functional and cross-functional programs to enhanced global full-service solutions. Combining RPS' global solutions and Asklep's localized services, we believe the JVC will address an unmet need in Japan."

About RPS  
ReSearch Pharmaceutical Services (RPS), the market leading global provider of innovative outsourcing Clinical Development Solutions, provides comprehensive Phase I-IV services to meet the evolving needs of the Biopharmaceutical, Medical Device and Diagnostic industries, customized by customer type (large, mid-size, and small).  Built organically, RPS is the fastest growing top 10 global Clinical Research Organization (CRO), with more than 5,000 employees and operations in more than 64 countries with proprietary internal structures.  These structures provide both RPS and its partner's greater development flexibility and growth.  RPS is uniquely positioned to provide the following customized clinical development solutions:

  • Large organizations: RPS provides innovative, Embedded, portfolio-wide clinical development solutions  delivering multi-million dollar cost savings, greater quality and the ability to manage more within their portfolio while retaining strategic control and effectively managing regulatory risk. 
  • Midsize organizations: RPS has leveraged its market leading Embedded Clinical Development Solutions expertise providing an innovative model that enables the efficient internal development of a midsize company's product portfolio with greater control and flexibility, accelerated development timelines and substantially reduced costs.
  • Virtual/Small Organizations: RPS provides a comprehensive project based delivery solution with market leading full service processes and tools.  Our in-house drug development expertise combined with outstanding project management means that our clients achieve superior execution on efficiently designed studies.  RPS recruits in excess of 100,000 patients a year with performance ahead of industry leading benchmarks.

For more information about RPS, visit www.rpsweb.com.

About Asklep   
Asklep, Inc., (www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services including monitoring, data management, biostatistics, and comprehensive CRA training. As a member of the Intage Group (http://www.intage.co.jp/), we provide full support service for drug development through medical research and system solutions.


'/>"/>
SOURCE ReSearch Pharmaceutical Services Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Doing Business in China: Research on Chinese Good Manufacturing Practice Regulations for Medical Devices
2. Quantum Materials Corporation Supplies Tetrapod Quantum Dots to U.S. Government Researchers
3. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
4. Family Tree DNAs Genomics Research Center Facilitates Discovery of Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree
5. RFID-over-Wi-Fi RTLS Temperature Sensing Solution Protects Clinical Research Specimens at Fred Hutchinson Cancer Research Center
6. Texas Research Institutions Conducted Over 8,200 Clinical Trials of Medicines Since 1999
7. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
8. New Research Indicating Serious Potential Risks To Cancer Patients From Oncology Drug Shortages
9. Millennium Research Group Sponsors Case Competition at Western University for Second Year
10. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
11. Hologics 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
Breaking Medicine Technology:
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
Breaking Medicine News(10 mins):